Artificial Intelligence

With mixed trial results for its obesity drug and rising costs, Skye Bioscience's upcoming 2025 earnings call is a pivotal moment for investors.

Biotech firm Immunis, Inc. secures a promising drug candidate to treat a debilitating side effect of Parkinson's therapy, offering hope to millions.

Kura Oncology's new AML drug, KOMZIFTI, sees rapid market uptake, strong financials, and an ambitious plan to reshape targeted cancer therapy.

Syntax Data launches Saidee, an AI that builds custom portfolios using proprietary, traceable data, aiming to solve key compliance fears for financial advisors.

As Singapore mandates e-invoicing, Cygnet.One leverages its global platform to simplify complex digital tax compliance for multinational enterprises.

Early data for zolucatetide shows it shrinks tumors in a rare genetic disease, cracking a long-undruggable cancer target and offering new hope.

Ad-tech giant Teads reports massive revenue growth post-merger, but a $352M impairment and restructuring signal deep integration challenges.

With $266M and 300MW of secured power, HighBrook Investors is tackling Northern Virginia's data center shortage, signaling a major PE shift.

Following key acquisitions, the AI firm pivots to a vertically integrated defense powerhouse, forecasting explosive growth backed by a swelling order backlog.

The deal merges Bonterra’s enterprise grantmaking with Deed’s modern employee engagement platform, signaling a major shift in corporate social responsibility.

A novel oral drug for Alzheimer's avoids a key side effect of current therapies, as its 'detangler' platform shows promise for Parkinson's and other diseases.

A new report finds AI boosts elite team productivity 4x, but warns that automating mid-level tasks could create a critical cybersecurity skills gap.

With $15M from top UAE families, TruDoc is scaling its 'hospital-at-home' model, signaling a major shift in how the GCC delivers critical care.

A Chinese firm's win at a top Korean battery expo signals a major shift in manufacturing tech, accelerating the path to cheaper, greener, solid-state batteries.

A Chinese firm's innovative probiotic packaging just won a top design award, solving a key industry problem and signaling a new era for 'Made in China'.

ST's new STM32C5 microcontroller series promises to bring high-end performance and robust security to billions of cost-sensitive smart devices.

CrowdStrike and Schwarz Digits partner to deliver AI-native security on a sovereign EU cloud, answering Europe's call for data control amid new regulations.

A new global survey reveals the crushing mental burden of diabetes, sparking a call for AI-powered tools that promise to restore spontaneity and control.

Phonak's new hearing aids won a top design award, blending advanced AI with discreet style to change how we see and hear with assistive technology.

Neobank Dave Inc. raises $175M in 0% interest notes while buying back stock, signaling deep confidence and a sophisticated new playbook for growth.